Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 27; no. 11; pp. 2262 - 2264
Main Authors:	Soderquist, R, Bates, D J P, Danilov, A V, Eastman, A
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-11-2013 Nature Publishing Group
Subjects:	631/67/1059/99 631/67/1990/283/1895 Apoptosis Biphenyl Compounds - pharmacology Blood cancer Cancer Cancer Research Care and treatment Chemotherapy, Combination Chronic lymphocytic leukemia Clinical trials Contraceptive Agents, Male - pharmacology Critical Care Medicine Drug resistance Drug Resistance, Neoplasm - drug effects Drug therapy Gossypol Gossypol - pharmacology Hematology Humans Intensive Internal Medicine letter-to-the-editor Letters to the editor Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - metabolism Leukemia, Lymphocytic, Chronic, B-Cell - pathology Leukocytes Lymphatic leukemia Lymphocytes Lymphoma Medicine Medicine & Public Health Nitrophenols - pharmacology Oncology Piperazines - pharmacology Proteins Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors Proto-Oncogene Proteins c-bcl-2 - metabolism Stroma Stromal Cells - drug effects Stromal Cells - pathology Sulfonamides - pharmacology Testing Tumor Cells, Cultured
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0887-6924 1476-5551
DOI:	10.1038/leu.2013.138